Scharlab adds Columbia CNA Agar for Isolation of Gram +ve Cocci
go back to news archives Scharlab have added Columbia CNA Agar to their catalogue of culture media. Widely used medium in the clinical laboratory for the selective isolation of Gram-positive cocci with the addition of defibrinated blood to the formulation. This medium owes its selectivity to the presence of two antibiotics: nalidixic acid and colistin. The advantage which this Scharlau medium offers regular users is that these antibiotics are already incorporated in its formulation, and there are no further additions necessary in the form of supplements. Nalidixic acid inhibits Enterobacteriaceae in particular, whereas Pseudomonas is especially susceptible to colistin. The combination of these antibiotics is very effective in allowing the growth and haemolytic reactions of Staphylococci, Streptococci, Enterococci and yeasts. |
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Scharlab,S.L. View Company Information
Posted on March 15, 2011
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
2025 Novogene Sequencing Symposium
8 May 2025 -
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
14 May 2025 -
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
14 May 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
19 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025 -
European Microbiology Conference and Workshop 2025
20 May 2025 -
Future Labs Live 2025
27 May 2025 -
2025 Endotoxin Testing Summit
10 Jun 2025